Entyvio 300 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQLP2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,899
Award facts
- Contract value 100% obligated
- $14,898.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,898.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. The award, issued on January 22, 2026, with an ultimate completion date of January 23, 2026, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract awarded on November 13, 2025, that positions the company as a critical regional pharmaceutical supplier for Department of Defense healthcare operations.
The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to consolidate pharmaceutical supply chains across the DoD's military healthcare facilities worldwide. As a prime vendor contractor under this initiative, DMS Pharmaceutical Group supplies a comprehensive portfolio of pharmaceuticals including branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals to support recurring medical supply needs of federal military healthcare operations. The company's established performance on numerous prior delivery orders and its certification as a woman-owned small business demonstrate its capability to fulfill the diverse and specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FQLP2?
SPE2DR26FQLP2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FQLP2 worth?
The government has obligated $14,899 on SPE2DR26FQLP2.
Is contract SPE2DR26FQLP2 an order under another contract?
Yes. SPE2DR26FQLP2 is a delivery order under SPE2DR25D9354, an indefinite delivery contract.
Was contract SPE2DR26FQLP2 competed?
The extent of competition for SPE2DR26FQLP2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award